Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike. - Wikidata - wikimedia - TriplyDB

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.

http://www.wikidata.org/entity/Q37863461

about

Improved clinical outcomes of high risk β thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy.Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies.Advances in conditioning regimens for older adults undergoing allogeneic stem cell transplantation to treat hematologic malignancies.Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation.Conditioning regimens in allo-SCT for thalassemia major.Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome.Long-term outcome after a treosulfan-based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies.Pulmonary hypertension following haematopoietic stem cell transplantation for primary haemophagocytic lymphohistiocytosis.Escalating topotecan in combination with treosulfan has acceptable toxicity in advanced pediatric sarcomas.Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia.Treosulfan Pharmacokinetics and its Variability in Pediatric and Adult Patients Undergoing Conditioning Prior to Hematopoietic Stem Cell Transplantation: Current State of the Art, In-Depth Analysis, and Perspectives.

P2860

Q34700498-CEB1582D-FEFE-44ED-976B-DF5E5D3589DE Q35859239-72B9D8B4-9184-49C6-9F7A-7CA02FE43C6B Q37990549-F2BC7D77-A4EB-4D7C-98F1-BF5D5DD1DBDB Q38095833-1304DE66-443E-4A39-AEF7-29A625E0F389 Q38105635-69B5BC71-2B82-416A-8480-C38ABD0A9709 Q38179977-417548F2-D2DE-42F7-B2F4-C63129EB30CB Q40214372-B46D1ACB-F9F7-481A-B9D1-CF3199E67D94 Q40280061-08133AC6-8267-4E6A-A4C0-D38AE6FA6C3D Q41519709-781391DC-1339-4D02-80F7-5462A7D00336 Q43967338-D230374E-794A-46D4-A0B8-6C31D60D0C6A Q45911250-DB739BA6-E929-4A09-BBA5-CAB06C4981BA Q47724804-62108358-0C2D-47CE-815B-84DF6A115AEB Q48162670-D1D9BF4B-6B12-4B92-8241-F39D61A5731F Q48165128-B9AA5832-59F9-4119-A2EA-06A01E3BCD67 Q50848271-CCFB8891-84D7-4B72-BFFC-B18F60E1BDF6 Q52647269-A97F32C2-5949-4988-AEAC-87E983C0F719

P2860

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.

http://www.wikidata.org/entity/Q37863461

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.

@en

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.

@nl

type

label

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.

@en

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.

@nl

prefLabel

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.

@en

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.

@nl

P1433

Q37863461-B65BA15B-1AAE-46B8-A091-827B3C307869

P1476

Q37863461-E2447194-8ACC-456C-82F8-7E120FCE9ACF

P2093

Q37863461-7BE1E979-32A4-4718-BF03-DAB0FE74AA43

Q37863461-95BC67DF-7823-407B-A998-9EBC8356F38A

Q37863461-B448AA54-C075-48FC-8976-76443BF6287B

P2860

Q37863461-040F9AFB-F995-4250-B931-34BB021EDC07

Q37863461-050D914A-B395-4333-8E96-324CD90742B6

Q37863461-0DE72576-A56F-453D-AF8A-D325C0004C60

Q37863461-0E0911A6-B2A9-405D-8C2C-4477D33D3B21

Q37863461-0F9C786F-D7BD-4486-80E0-946561912A41

Q37863461-1227665B-1004-485D-B6AE-6983353ABA68

Q37863461-174B0E95-0DCA-4A5D-8AC2-D7E202E44DAE

Q37863461-1C011E08-AF4D-4F00-9858-AF21E1CABB3B

Q37863461-26324C32-32C7-46DE-8271-4BF4372B6E40

Q37863461-28DD799D-4DE3-4577-8992-FCFBB577EC79

P2888

Q37863461-54FE72C7-D8AC-40F0-A646-F08C6F47BBC9

P304

Q37863461-82EA1B2C-18F0-42D6-AF93-00A3A0B67972

P31

Q37863461-A69ED80C-75B6-4CA7-99A1-AA92CC227026

P356

Q37863461-35DDC64F-F088-4DB9-BB7C-7AD0CC756B5B

P407

Q37863461-34CB9223-E4D1-4CDA-B80C-28DF7D4E1AC2

P433

Q37863461-10AA6D3F-7234-4FE8-94E6-FBC315DE7274

P478

Q37863461-9D79F1BA-E443-4CCB-B02F-3917CA18F7C2

P577

Q37863461-DCB74C53-730C-4E1C-8957-CD847D322213

P5875

Q37863461-A3284457-0785-4A6E-A334-F2DE72148CC5

P6179

Q37863461-789BD316-03A2-4474-98BC-550F1D324BE0

P698

Q37863461-9A4BC8EA-75BC-4655-A22C-87377683F163

P356

P1433

Bone Marrow Transplantation

P1476

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.

@en

P2093

A Nagler

http://www.w3.org/2001/XMLSchema#string

A Shimoni

http://www.w3.org/2001/XMLSchema#string

I Danylesko

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the intensity of conditioning regimens: working definitions

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy.

Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect.

Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

Cytokines, viruses, and graft-versus-host disease.

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

The pathophysiology of acute graft-versus-host disease.

Pharmacokinetics of high-dose chemotherapy.

P2888

P304

5-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2011.88

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51037868

http://www.w3.org/2001/XMLSchema#string

P6179

1049674859

http://www.w3.org/2001/XMLSchema#string

P698

21478921

http://www.w3.org/2001/XMLSchema#string